Purchase Order W81K0217P0224
- Not listed
- This firm fixed-price purchase order contract was awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense to Illumina, Inc., a manufacturer of genomic sequencing systems and analytical tools. The $282,150.00 contract provides for the delivery of a MiSeq diagnostic sequencing system to support research and analysis at the U.S. Army's Fort Detrick facility in Maryland. Illumina has previously provided sequencing platforms and related services to federal agencies including the...
- This is a firm fixed price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The contract, valued at $680,732.58, is for the delivery of a MiSeq FGx Sequencing System, which supports genetic and genomic analysis. The contract has no set-aside designation. Illumina has a history of providing sequencing systems and related goods and services to various federal agencies such as the National...
- This firm fixed-price purchase order contract was awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract has a ceiling value of $75,240.00 and is for the provision of a MiSeq System. The award does not have a set-aside designation. Illumina has previously delivered sequencing systems and services to federal agencies such as the National Institutes of Health, Centers for Disease Control and...
- This is a firm fixed-price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of sequencing and analytical instrumentation and reagents. The contract, valued at $95,931.00, is for the procurement of an SY-410-1003 ASSY, TLA, MISEQ2 item. The contract has no set-aside designation and is intended to support Illumina's provision of sequencing systems, reagents, and services to MEDCOM and its research activities. Illumina has a history of...
- This is a firm fixed-price purchase order contract awarded by the U.S. Army Medical Command to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions. The contract is for a SEQUENCING SYSTEM with a ceiling value of $1,084,390.80 and a period of performance that runs through November 22, 2020. The contract does not have a set-aside designation. Illumina has provided sequencing systems, reagents, and services to support genomic research and analysis for various federal...
- This firm fixed-price purchase order, valued at $2,881,079.36, was awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of genetic sequencing products and services. The contract supports genomic sequencing and analysis needs, with Illumina providing a range of sequencing systems, reagents, and bioinformatics products. This award does not have a set-aside designation. Illumina has previously received prime contract and subcontract awards from various federal...
- This is a firm fixed price purchase order for $367,269.00 awarded by the Medical Command (MEDCOM) division of the U.S. Army to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract is for a NextSeq 500 sequencing system, with an ultimate completion date of November 18, 2020. Illumina has provided similar sequencing systems and related products and services to various federal agencies like the NIH, CDC, USDA, and VA in the past. This award is not...
- This is a firm fixed price delivery order contract valued at $242,110.64 awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of Illumina reagents to support the agency's sequencing and genomic analysis needs, without any set-aside designation. Illumina has a history of supporting federal agencies like the NIH, CDC, USDA, and VA with its sequencing systems and related products and...
- This is a firm fixed price delivery order contract awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract has a ceiling value of $473,964.67 and is for the provision of various Illumina reagents, with a period of performance through October 28, 2015. This appears to be part of a larger Indefinite Delivery Contract that Illumina holds with the Department of the Navy Bureau of...
- This is a firm-fixed-price purchase order awarded by the Naval Medical Research Command to Illumina, Inc., a for-profit manufacturer of genomic sequencing technologies. The requirement is for a MiSeq i100 Plus System, a specialized DNA/RNA sequencing instrument. The $90,997.20 contract has an ultimate completion date of July 30, 2025. Illumina is a prime contractor providing a range of genomic sequencing platforms, reagents, consumables, and maintenance services to multiple federal civilian...
This is a firm fixed price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The contract, valued at $95,931.00, is for the delivery of a MiSeq System, a DNA sequencing instrument used for genomic research and diagnostics. While Illumina has previously received prime contract and sub-contract awards from other federal agencies such as the NIH, CDC, USDA, and VA to provide a range of its sequencing products and services, this specific award does not appear to be associated with a larger contract vehicle. The contract has no set-aside designation. Illumina has supported the government's nucleic acid sequencing needs through an Indefinite Delivery Contract with the Department of the Navy Bureau of Medicine and Surgery as well.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Benchtop Sequencer | W81K02-17-P-0224 | Department of the Army Medical Command | Award Notice 1/1 | 4/11/17, 4:18 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $95.9k | 4/5/17 |